Onkure Therapeutics Releases Q2 2026 Financial Results
AlphaStreet Newsdesk powered by AlphaStreet Intelligence OKUR|EPS -$0.31|Net Loss $15.3M Onkure Therapeutics Inc (OKUR) reported Q2 2026 basic and diluted ...
Wednesday, August 5, 2026
Tag: Therapeutics
Protagonist Therapeutics Inc. (PTGX): Billionaire Joe Edelman Likes This Stock
We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ranks ...
Protagonist Therapeutics Jumps 7.0% in Broad Rally
Riding the sector wave. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) surged 7.0% to $104.39 on Tuesday, April 14, 2026, as a ...
Neumora Therapeutics 2025 Financial Update
NMRA|EPS -$0.35|Net Loss $59.4M Neumora Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for brain diseases. Based ...
Avalo Therapeutics 2025 Financial Review
Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s ...
MindBio Therapeutics upsizes private placement to $1.5M (OTC Markets:MBQIF)
Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock news MindBio Therapeutics ...
Dogwood Therapeutics, Inc. (DWTX) Q4 2025 Earnings Results
Loss Per Share (GAAP) $0.26 Loss narrows sharply. Dogwood Therapeutics, Inc. (NASDAQ: DWTX) reported a loss of $0.26 per share ...
Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance
Soleno Therapeutics (NASDAQ:SLNO) is one of the 17 biotechnology stocks with more than 50% upside. On January 20, the price ...
-1024x683.jpg "Michigan – The Sum of Democrat Fears")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.